Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.40 +0.03 (+7.30%)
As of: Oct 23, 2026 · 3:59 PM EDT

Citius Pharmaceuticals (CTXR) Return on Capital Employed [ROCE] (2016 - 2026)

Updated

Citius Pharmaceuticals (CTXR) recorded Return on Capital Employed [ROCE] of -71.59% in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 15.03 percentage points from -56.56% a year earlier but up 0.16 percentage points from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Return on Capital Employed [ROCE] (2016 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals reported Return on Capital Employed [ROCE] of -48.84%, up 7.67 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of +0.13 percentage points (FY2020 to FY2025).
  • Across earlier fiscal years, Return on Capital Employed [ROCE] came in at -56.51% in FY2024 (-20.86 pp), -35.65% in FY2023 (-8.72 pp), -26.94% in FY2022 (-0.53 pp) and -26.41% in FY2021 (+22.57 pp).
  • Quarterly Return on Capital Employed [ROCE] has ranged from -71.75% in fiscal Q2 2026 to -16.75% in fiscal Q4 2021 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in two of the last eight quarters, with an average year-over-year change of -7.63 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 40.93 percentage points in fiscal Q1 2022, against a drop of 22.82 percentage points in fiscal Q4 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -71.75% (Q2 2026), -38.48% (Q1 2026) and -45.65% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.52%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 17.92%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 6.28%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 16.76%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -5.97%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.86%
10 Citius Pharmaceuticals 10.47 Mn -23.10 Mn 1.00 Mn -71.59%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -71.59%
Mar 31, 2026 -71.75%
Dec 31, 2025 -38.48%
Sep 30, 2025 -45.65%
Jun 30, 2025 -56.56%
Mar 31, 2025 -60.36%
Dec 31, 2024 -57.80%
Sep 30, 2024 -59.10%
Jun 30, 2024 -45.76%
Mar 31, 2024 -43.51%
Dec 31, 2023 -40.90%
Sep 30, 2023 -36.29%
Jun 30, 2023 -33.64%
Mar 31, 2023 -33.81%
Dec 31, 2022 -28.90%
Sep 30, 2022 -29.58%
Jun 30, 2022 -25.90%
Mar 31, 2022 -21.80%
Dec 31, 2021 -18.57%
Sep 30, 2021 -16.75%
API Access

Citius Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CTXR&period=max&api_key=YOUR_API_KEY